The reclassification of misoprostol and mifepristone is a public health crisis that it will delay essential care, particularly in emergencies like postpartum hemorrhaging, which could have life-threatening consequences. Hospitals are already pulling these drugs from obstetric carts, raising concerns about rapid access to life-saving treatments. Jennifer Avegno, New Orleans Health Director, joins guest host Ian Hoch to discuss it.